Showing 1 - 10 of 23
The nature of the observed market structure and R&D competition in genomics research is used as the basis for a comparative analysis of research under a mixed oligopoly, pure oligopoly and monopoly when the timing of the innovation outcome is uncertain (as in an R&D race), the winner-take-all...
Persistent link: https://www.econbiz.de/10009442861
Replaced with revised version of paper 04/21/06.
Persistent link: https://www.econbiz.de/10009445319
Despite the clear influence of European Union biotechnology restrictions on trade patterns, very little work has been done to model these influences or their long-run effects. This paper presents an economic trade theory model of biotechnology, biotechnology research and development (R&D), and...
Persistent link: https://www.econbiz.de/10009446224
This paper calculates the rate of return to a set of cowpea research, extension and distribution projects in Senegal to be between 31% and 92%. The results show that a modestly funded program on a secondary crop can be successful. They also indicate that programs may increase their effectiveness...
Persistent link: https://www.econbiz.de/10010911340
Persistent link: https://www.econbiz.de/10010911407
Most of the empirical literature calculating rates of return to publicly sponsored research assumes that research is the only relevant government intervention. For most countries this assumption is untenable. This paper shows that improperly measuring government induced market distortions can...
Persistent link: https://www.econbiz.de/10010911444
It is often argued that public support of agricultural research is inadequate. However, the empirical papers that support this hypothesis rarely reflect formal behavioral theory capable of explaining this phenomenon. This paper presents a theory that explains underfunding, namely, that funding...
Persistent link: https://www.econbiz.de/10010911528
Persistent link: https://www.econbiz.de/10010917280
Persistent link: https://www.econbiz.de/10011252079
This paper examines the impact of European Union policy on genetically modified organisms on trade flows and economic growth. Restrictive European Union policies on biotech production and consumption result in: an effective export subsidy of capital to the South; new trade flows; North America...
Persistent link: https://www.econbiz.de/10005321029